Table 1.
Baseline characteristics of study population
| Patients with mild CHD n = 69 | Patients with severe CHD n = 36 | P | |
|---|---|---|---|
| Age (mean ± SD) | 59.05 ± 10.5 | 62.36 ± 9.5 | |
| Female (%) | 25(36.2%) | 12(33.3%) | 0.8 |
| History of DM (%) | 14(20.3%) | 12(33.3%) | 0.07 |
| History of DLP (%) | 25(36.2%) | 19(52.8%) | 0.05 |
| History of HTN (%) | 23(33.3%) | 17(47.2%) | 0.08 |
| HP positive (%) | 17(47.2) | 30(43.4%) | 0.28 |
| CagA positive (%) | 10(27.7) | 17(24.63) | 0.65 |
| CRP level (%) | 7(10.1%) | 8(22.2%) | 0.04 |
| IL-6 ≥ 14 (%) | 4 (30.8%) | 9(69.2%) | 0.01 |
DM: Diabetes mellitus, DLP: Dyslipidemia, HTN: Hypertension, CRP: C-reactive protein, IL-6: Interlukine-6, HP: Helicobacter pylori, CagA: Cytotoxin-associated gene A